ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Fractyl Health Inc

Fractyl Health Inc (GUTS)

2.09
0.03
( 1.46% )
Actualizado: 14:08:39

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
2.09
Postura de Compra
2.09
Postura de Venta
2.10
Volume Operado de la Acción
171,286
2.01 Rango del Día 2.19
1.74 Rango de 52 semanas 14.50
Capitalización de Mercado [m]
Precio Anterior
2.06
Precio de Apertura
2.08
Última hora de negociación
14:10:47
Volumen financiero
US$ 356,878
Precio Promedio Ponderado
2.0835
Volumen promedio (3 m)
358,044
Acciones en circulación
2,095,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.05
Beneficio por acción (BPA)
-45
turnover
120k
Beneficio neto
-94.27M

Acerca de Fractyl Health Inc

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Fractyl Health Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker GUTS. The last closing price for Fractyl Health was US$2.06. Over the last year, Fractyl Health shares have traded in a share price range of US$ 1.74 to US$ 14.50.

Fractyl Health currently has 2,095,000 shares in issue. The market capitalisation of Fractyl Health is US$4.32 million. Fractyl Health has a price to earnings ratio (PE ratio) of -0.05.

GUTS Últimas noticias

Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates

REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 Anticipate reporting data from REVEAL-1 open-label cohort beginning in Q4...

Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024

13-week follow-up represents the longest data to-date demonstrating durable efficacy of RJVA-001 on weight and blood sugar in the diet-induced obesity (DIO) mouse model Company plans to use...

Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024

Single Revita procedure led to sustained, clinically meaningful weight loss in majority of patients with Type 2 Diabetes REMAIN-1 weight maintenance pivotal study on-track to report mid-point data...

Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024

BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024

BURLINGTON, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference

BURLINGTON, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Fractyl Health to Participate in Upcoming September Investor Conferences

BURLINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.29-12.18487394962.382.381.913610312.07357066CS
4-0.3375-13.9031925852.42753.4811.914743582.61259165CS
12-1.32-38.70967741943.413.721.913580442.7003187CS
26-4.81-69.71014492756.97.891.743186183.18579256CS
52-11.66-84.813.7514.51.743204615.05624317CS
156-11.66-84.813.7514.51.743204615.05624317CS
260-11.66-84.813.7514.51.743204615.05624317CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CRNCCerence Inc
US$ 6.099
(116.28%)
71.27M
WORXSCWorx Corporation
US$ 2.05
(109.18%)
131.71M
ARQQArqit Quantum Inc
US$ 10.7901
(47.00%)
743.81k
SPAISafe Pro Group Inc
US$ 4.61
(44.06%)
39.82M
PROCProcaps Group SA
US$ 0.771
(34.91%)
1.2M
SKKSKK Holdings Limited
US$ 0.8365
(-81.66%)
28M
TMTCTMT Acquisition Corporation
US$ 2.43
(-62.27%)
360.04k
WCTWellchange Holdings Company Limited
US$ 1.2657
(-61.88%)
1.95M
TMTCUTMT Acquisition Corporation
US$ 2.99
(-55.24%)
11.76k
GLXGGalaxy Payroll Group Ltd
US$ 1.81
(-53.71%)
2.23M
CDTConduit Pharmaceuticals Inc
US$ 0.1078
(16.79%)
554.41M
NVDANVIDIA Corporation
US$ 147.62
(1.19%)
324.48M
ELABElevai Labs Inc
US$ 0.0202
(-5.61%)
220.57M
AKTSAkoustis Technologies Inc
US$ 0.102
(17.11%)
200.32M
MARAMARA Holdings Inc
US$ 24.374
(7.71%)
139.59M

Su Consulta Reciente

Delayed Upgrade Clock